TD Waterhouse Canada’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$19.3M Sell
677,398
-97,894
-13% -$2.61M 0.06% 192
2025
Q4
$19.3M Buy
775,292
+6,595
+0.9% +$166K 0.12% 138
2025
Q3
$20.8M Buy
768,697
+29,454
+4% +$727K 0.14% 135
2025
Q2
$18.5M Sell
739,243
-266,469
-26% -$6.21M 0.13% 134
2025
Q1
$25.7M Buy
1,005,712
+218,645
+28% +$5.72M 0.21% 97
2024
Q4
$20.9M Sell
787,067
-153,811
-16% -$4.17M 0.17% 111
2024
Q3
$26.9M Buy
940,878
+30,251
+3% +$882K 0.22% 92
2024
Q2
$25.7M Sell
910,627
-199,627
-18% -$5.5M 0.23% 88
2024
Q1
$34M Buy
1,110,254
+403,104
+57% +$11.2M 0.25% 76
2023
Q4
$23.3M Sell
707,150
-40,760
-5% -$1.23M 0.22% 89
2023
Q3
$29.4M Sell
747,910
-22,488
-3% -$795K 0.31% 62
2023
Q2
$31.7M Sell
770,398
-332,303
-30% -$12.9M 0.32% 59
2023
Q1
$49.7M Sell
1,102,701
-93,010
-8% -$4.02M 0.51% 42
2022
Q4
$67.8M Sell
1,195,711
-4,386
-0.4% -$210K 0.74% 32
2022
Q3
$58.4M Sell
1,200,097
-2,310
-0.2% -$112K 0.66% 34
2022
Q2
$68.1M Sell
1,202,407
-66,302
-5% -$3.38M 0.77% 30
2022
Q1
$69.9M Sell
1,268,709
-2,720
-0.2% -$141K 0.68% 32
2021
Q4
$73.6M Buy
+1,271,429
New +$63M 0.72% 34

Other funds holding PFE

TD Waterhouse Canada's PFE Position: Q1 2026 in Review

TD Waterhouse Canada reduced its Pfizer (PFE) stake by 13% in Q1 2026, selling an estimated $2.61M and leaving 677,398 shares worth $19.3M. The position accounts for 0.06% of the portfolio, ranked #192.

TD Waterhouse Canada first reported a position in PFE in Q4 2021 and has held it in 18 quarters since. The position peaked at $73.6M in Q4 2021. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • TD Waterhouse Canada held 677,398 shares of Pfizer worth $19.3M as of Q1 2026.
  • TD Waterhouse Canada sold 97,894 Pfizer shares in Q1 2026, an estimated $2.61M.
  • Pfizer made up 0.06% of TD Waterhouse Canada's portfolio in Q1 2026, its #192 holding.
  • TD Waterhouse Canada first reported a position in Pfizer in Q4 2021 and has held it in 18 quarters since.
  • TD Waterhouse Canada's Pfizer position peaked at $73.6M in Q4 2021.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on TD Waterhouse Canada's 13F filing for Q1 2026, filed 12 May 2026.